Skip to Main Content

Paper Details

NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
N Engl J Med
145
2017
3-hydroxyanthranilic acid, 3-hydroxyanthranilic acid 3,4-dioxygenase, CRISPR, Cas9, Congenital Malformations, Congenital malformations, HAAO, Haao, KYNU, KYNU p., KYNU proteins, KYNU variants, Kynu, NAD, NAD Deficiency, NAD deficiency, Niacin, Nicotinamide adenine dinucleotide, V57Efs, W186, cardiac, vertebral, and renal defects, clustered regularly interspaced short palindromic repeats, congenital malformations, deficiency of NAD, gene variants, kynureninase, kynurenine, mice, mouse, p, tryptophan
Author NameAffiliation
Felicity CollinsVictor Chang Cardiac Research Institute, University of New South Wales (H.S., Liverpool Hospital, Children's Hospital at Westmead, D.O.S.) and the Medical School (D.S.W.), University of Sydney, Macquarie University (C.K.L., University of Adelaide, and the Institute of Health and Biomedical Innovation, Queensland University of Technology (A.M.M.-L., the Translational Research Institute (A.M.M.-L., Royal Brisbane and Women's Hospital (E.L.D.), and the University of Queensland School of Medicine (E.L.D.)
David SillenceVictor Chang Cardiac Research Institute, University of New South Wales (H.S., Liverpool Hospital, Children's Hospital at Westmead, D.O.S.) and the Medical School (D.S.W.), University of Sydney, Macquarie University (C.K.L., University of Adelaide, and the Institute of Health and Biomedical Innovation, Queensland University of Technology (A.M.M.-L., the Translational Research Institute (A.M.M.-L., Royal Brisbane and Women's Hospital (E.L.D.), and the University of Queensland School of Medicine (E.L.D.)
Joshua W K HoVictor Chang Cardiac Research Institute, University of New South Wales (H.S., Liverpool Hospital, Children's Hospital at Westmead, D.O.S.) and the Medical School (D.S.W.), University of Sydney, Macquarie University (C.K.L., University of Adelaide, and the Institute of Health and Biomedical Innovation, Queensland University of Technology (A.M.M.-L., the Translational Research Institute (A.M.M.-L., Royal Brisbane and Women's Hospital (E.L.D.), and the University of Queensland School of Medicine (E.L.D.)
Joshua W K HoVictor Chang Cardiac Research Institute, University of New South Wales (H.S., Liverpool Hospital, Children's Hospital at Westmead, D.O.S.) and the Medical School (D.S.W.), University of Sydney, Macquarie University (C.K.L., University of Adelaide, and the Institute of Health and Biomedical Innovation, Queensland University of Technology (A.M.M.-L., the Translational Research Institute (A.M.M.-L., Royal Brisbane and Women's Hospital (E.L.D.), and the University of Queensland School of Medicine (E.L.D.)
Matthew A BrownVictor Chang Cardiac Research Institute, University of New South Wales (H.S., Liverpool Hospital, Children's Hospital at Westmead, D.O.S.) and the Medical School (D.S.W.), University of Sydney, Macquarie University (C.K.L., University of Adelaide, and the Institute of Health and Biomedical Innovation, Queensland University of Technology (A.M.M.-L., the Translational Research Institute (A.M.M.-L., Royal Brisbane and Women's Hospital (E.L.D.), and the University of Queensland School of Medicine (E.L.D.)
Eleni GiannoulatouVictor Chang Cardiac Research Institute, University of New South Wales (H.S., Liverpool Hospital, Children's Hospital at Westmead, D.O.S.) and the Medical School (D.S.W.), University of Sydney, Macquarie University (C.K.L., University of Adelaide, and the Institute of Health and Biomedical Innovation, Queensland University of Technology (A.M.M.-L., the Translational Research Institute (A.M.M.-L., Royal Brisbane and Women's Hospital (E.L.D.), and the University of Queensland School of Medicine (E.L.D.)
  • 1 - 6

Datasets

Release 1.2